Rodent models of nicotine reward: What do they tell us about tobacco abuse in humans?

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 4, 2009, Pages 481-488

  O'Dell, Laura E ^a   Khroyan, Taline V ^b  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

Adolescent; Brain reward; Dependence; Nicotine addiction; Place conditioning; Self administration; Sex; Stress

Indexed keywords

NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; CONSTRUCT VALIDITY; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FACE VALIDITY; FEMALE; GROUPS BY AGE; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RAT; REVIEW; REWARD; RODENT; SELF STIMULATION; SEX RATIO; SEXUAL BEHAVIOR; STRESS; TOBACCO; TOBACCO DEPENDENCE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; NICOTINE; NICOTINIC AGONISTS; RATS; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

ANIMALIA; NICOTIANA TABACUM; RODENTIA;

EID: 58349092724     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.12.011     Document Type: Review

References (78)

1. Agatsuma S., Lee M., Zhu H., Chen K., Shih J.C., Seif I., et al. Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum Mol Genet 15 (2006) 2721-2731
2. Belluzzi J.D., Lee A.G., Oliff H.S., and Leslie F.M. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology 174 (2004) 389-395
3. Belluzzi J.D., Wang R., and Leslie F.M. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30 (2005) 705-712
4. Berlin I., and Anthenelli R.M. Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 4 (2001) 33-42
5. Biala G., and Budzynska B. Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists. Eur J Pharmacol 537 (2006) 85-93
6. Brielmaier J.M., McDonald C.G., and Smith R.F. Nicotine place preference in a biased conditioned place preference design. Pharmacol Biochem Behav 89 (2008) 94-100
7. Bruijnzeel A.W., and Gold M.S. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Res Brain Res Rev 49 (2005) 505-528
8. Bruijnzeel A.W., Zislis G., Wilson C., and Gold M.S. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 32 (2007) 955-963
9. Buczek Y., Le A.D., Wang A., Stewart J., and Shaham Y. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology 144 (1999) 183-188
10. Caggiula A.R., Donny E.C., White A.R., Chaudhri N., Booth S., Gharib M.A., et al. Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology 163 (2002) 230-237
11. Chen H., Matta S.G., and Sharp B.M. Acquisition of nicotine self-administration in adolescent rats given prolonged access to the drug. Neuropsychopharmacology 32 (2007) 700-709
12. Chen H., Fu Y., and Sharp B.M. Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal responses to mild acute stress. Neuropsychopharmacology 33 (2008) 721-730
13. Corrigall W.A. Understanding brain mechanisms in nicotine reinforcement. Br J Addict 86 (1991) 507-510
14. Corrigall W.A., and Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99 (1989) 473-478
15. Cousins M.S., Stamat H.M., and de Wit H. Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology 157 (2001) 243-253
16. Cryan J.F., Bruijnzeel A.W., Skjei K.L., and Markou A. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology 168 (2003) 347-358
17. Donny E.C., Caggiula A.R., Mielke M.M., Booth S., Gharib M.A., Hoffman A., et al. Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology 147 (1999) 135-142
18. Donny E.C., Caggiula A.R., Rowell P.P., Gharib M.A., Maldovan V., Booth S., et al. Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology 151 (2000) 392-405
19. Epping-Jordan M.P., Watkins S.S., Koob G.F., and Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393 (1998) 76-79
20. Fowler J.S., Logan J., Wang G.J., and Volkow N.D. Monoamine oxidase and cigarette smoking. Neurotoxicology 24 (2003) 75-82
21. Goldberg S.R., Spealman R.D., and Goldberg D.M. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214 (1981) 573-575
22. Grabus S.D., Martin B.R., Brown S.E., and Damaj M.I. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology 184 (2006) 456-463
23. Green T.A., Crooks P.A., Bardo M.T., and Dwoskin L.P. Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices. Biochem Pharmacol 62 (2001) 1597-1603
24. Henningfield J., Pankow J., and Garrett B. Ammonia and other chemical base tobacco additives and cigarette nicotine delivery: issues and research needs. Nicotine Tob Res 6 (2004) 199-205
25. Hertling I., Ramskogler K., Dvorak A., Klingler A., Saletu-Zyhlarz G., Schoberberger R., et al. Craving and other characteristics of the comorbidity of alcohol and nicotine dependence. Eur Psychiatry 20 (2005) 442-450
26. Huston-Lyons D., Sarkar M., and Kornetsky C. Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide. Pharmacol Biochem Behav 46 (1993) 453-457
27. Jackson K.J., Martin B.R., Changeux J.P., and Damaj M.I. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325 (2008) 302-312
28. Johnson P.M., Hollander J.A., and Kenny P.J. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav 90 (2008) 409-415
29. Kenny P.J., and Markou A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31 (2006) 1203-1211
30. Kota D., Martin B.R., Robinson S.E., and Damaj M.I. Nicotine dependence and reward differ between adolescent and adult male mice. J Pharmacol Exp Ther 322 (2007) 399-407
31. Le Foll B., and Goldberg S.R. Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology 178 (2005) 481-492
32. Lerman C., LeSage M.G., Perkins K.A., O'Malley S.S., Siegel S.J., Benowitz N.L., et al. Translational research in medication development for nicotine dependence. Nat Rev Drug Discov 6 (2007) 746-762
33. LeSage M.G., Keyler D.E., Collins G., and Pentel P.R. Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations. Psychopharmacology 170 (2003) 278-286
34. LeSage M.G., Burroughs D., Dufek M., Keyler D.E., and Pentel P.R. Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacol Biochem Behav 79 (2004) 507-513
35. Levin E.D., Rezvani A.H., Montoya D., Rose J.E., and Swartzwelder H.S. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology 169 (2003) 141-149
36. Levin E.D., Lawrence S.S., Petro A., Horton K., Rezvani A.H., Seidler F.J., et al. Adolescent vs. adult-onset nicotine self-administration in male rats: duration of effect and differential nicotinic receptor correlates. Neurotoxicol Teratol 29 (2007) 458-465
37. Liechti M.E., and Markou A. Role of the glutamatergic system in nicotine dependence: implications for the discovery and development of new pharmacological smoking cessation therapies. CNS Drugs 22 (2008) 705-724
38. Lutfy K., Brown M.C., Nerio N., Aimiuwu O., Tran B., Anghel A., et al. Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis. J Neurochem 99 (2006) 1321-1327
39. Malin D.H. Nicotine dependence: studies with a laboratory model. Pharmacol Biochem Behav 70 (2001) 551-559
40. Malin D.H., Lake J.R., Smith T.D., Khambati H.N., Meyers-Paal R.L., Montellano A.L., et al. Bupropion attenuates nicotine abstinence syndrome in the rat. Psychopharmacology 184 (2006) 494-503
41. Martellotta M.C., Kuzmin A., Zvartau E., Cossu G., Gessa G.L., and Fratta W. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 52 (1995) 271-274
42. Martin-Garcia E., Barbano M.F., Galeote L., and Maldonado R. New operant model of nicotine-seeking behaviour in mice. Int J Neuropsychopharmacol (2008) 1-14
43. Martin J.L., and Itzhak Y. 7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion. Neuroreport 11 (2000) 947-949
44. McClernon F.J., and Gilbert D.G. Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond. Nicotine Tob Res 6 (2004) 941-959
45. Merritt L.L., Martin B.R., Walters C., Lichtman A.H., and Damaj M.I. The endogenous cannabinoid system modulates nicotine reward and dependence. J Pharmacol Exp Ther 326 (2008) 483-492
46. Mooney M.E., and Sofuoglu M. Bupropion for the treatment of nicotine withdrawal and craving. Expert Rev Neurotherapeutics 6 (2006) 965-981
47. O'Dell L.E. A psychobiological framework of the substrates that mediate nicotine use during adolescence. Neuropharmacology (2009)
48. O'Dell L.E., and Koob G.F. Nicotine deprivation effect' in rats with intermittent 23 h access to intravenous nicotine self-administration. Pharmacol Biochem Behav 86 (2007) 346-353
49. O'Dell L.E., Bruijnzeel A.W., Ghozland S., Markou A., and Koob G.F. Nicotine withdrawal in adolescent and adult rats. Ann N Y Acad Sci 1021 (2004) 167-174
50. O'Dell L.E., Chen S.A., Smith R.T., Specio S.E., Balster R.L., Paterson N.E., et al. Extended access to nicotine self-administration leads to dependence: circadian measures, withdrawal measures, and extinction behavior in rats. J Pharmacol Exp Ther 320 (2007) 180-193
51. O'Dell L.E., Torres O.V., Natividad L.A., and Tejeda H.A. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats. Neurotoxicol Teratol 29 (2007) 17-22
52. Panagis G., Kastellakis A., Spyraki C., and Nomikos G. Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward. Psychopharmacology 149 (2000) 388-396
53. Parrott A.C. Stress modulation over the day in cigarette smokers. Addiction 90 (1995) 233-244
54. Paterson N.E., and Markou A. Animal models and treatments for addiction and depression co-morbidity. Neurotox Res 11 (2007) 1-32
55. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391 (1998) 173-177
56. Rauhut A.S., Neugebauer N., Dwoskin L.P., and Bardo M.T. Effect of bupropion on nicotine self-administration in rats. Psychopharmacology 169 (2003) 1-9
57. Risinger F.O., and Oakes R.A. Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol Biochem Behav 51 (1995) 457-461
58. Sahraei H., Falahi M., Zarrindast M.R., Sabetkasaei M., Ghoshooni H., and Khalili M. The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice. Eur J Pharmacol 503 (2004) 81-87
59. Schnoll R.A., Patterson F., and Lerman C. Treating tobacco dependence in women. J Womens Health (Larchmt) 16 (2007) 1211-1218
60. Seeman J.I., Dixon M., and Haussmann H.J. Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker. Chem Res Toxicol 15 (2002) 1331-1350
61. Sharp B.M., and Beyer H.S. Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J Pharmacol Exp Ther 238 (1986) 486-491
62. Shram M.J., Funk D., Li Z., and Le A.D. Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine. Psychopharmacology 186 (2006) 201-208
63. Spina L., Fenu S., Longoni R., Rivas E., and Di Chiara G. Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition. Psychopharmacology 184 (2006) 447-455
64. Stoker A.K., Semenova S., and Markou A. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropharmacology 54 (2008) 1223-1232
65. Stolerman I.P., and Jarvis M.J. The scientific case that nicotine is addictive. Psychopharmacology 117 (1995) 2-10 (discussion 14-20)
66. Stolerman I.P., Naylor C., Elmer G.I., and Goldberg S.R. Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology 141 (1999) 297-306
67. Suzuki T., Ise Y., Tsuda M., Maeda J., and Misawa M. Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol 314 (1996) 281-284
68. Talhout R., Opperhuizen A., and van Amsterdam J.G. Role of acetaldehyde in tobacco smoke addiction. Eur Neuropsychopharmacol 17 (2007) 627-636
69. Torrella T.A., Badanich K.A., Philpot R.M., Kirstein C.L., and Wecker L. Developmental differences in nicotine place conditioning. Ann N Y Acad Sci 1021 (2004) 399-403
70. Torres O.V., Tejeda H.A., Natividad L.A., and O'Dell L.E. Enhanced vulnerability to the rewarding effects of nicotine during the adolescent period of development. Pharmacol Biochem Behav 90 (2008) 658-663
71. Vastola B.J., Douglas L.A., Varlinskaya E.I., and Spear L.P. Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 77 (2002)
72. Villegier A.S., Lotfipour S., McQuown S.C., Belluzzi J.D., and Leslie F.M. Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52 (2007) 1415-1425
73. Walters C.L., Cleck J.N., Kuo Y.C., and Blendy J.A. Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 46 (2005) 933-943
74. Walters C.L., Brown S., Changeux J.P., Martin B., and Damaj M.I. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology 184 (2006) 339-344
75. Ward M.M., Swan G.E., and Jack L.M. Self-reported abstinence effects in the first month after smoking cessation. Addict Behav 26 (2001) 311-327
76. Wilkinson J.L., and Bevins R.A. Intravenous nicotine conditions a place preference in rats using an unbiased design. Pharmacol Biochem Behav 88 (2008) 256-264
77. Willner. Methods for assessing the validity of animal models of human psychopathology. In: A. Boulton G.B., and Martin-Iverson M. (Eds). Neuromethods: Animal models in psychiatry (1991), Humana Press, Clifton, NJ 1-23
78. Zislis G., Desai T.V., Prado M., Shah H.P., and Bruijnzeel A.W. Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 53 (2007) 958-966